In its Q2 2026 investor letter, Conestoga Capital Advisors highlighted LeMaitre Vascular, Inc. (NASDAQ:LMAT).
LeMaitre Vascular, Inc. (NASDAQ:LMAT) is a medical device company focusing on the manufacturing and development of products and services for vascular surgery
On August 5, 2026, LeMaitre Vascular, Inc. (NASDAQ:LMAT) closed at $79.00 per share, reflecting a market capitalization of $1.81 billion. LeMaitre Vascular, Inc. (NASDAQ:LMAT) posted a one-month return of -22.85%, while its shares lost 16.19% over the past 52 weeks. Conestoga Capital Advisors stated the following regarding LeMaitre Vascular, Inc. (NASDAQ:LMAT) in its Q2 2026 investor letter: “LeMaitre Vascular, Inc. (NASDAQ:LMAT) delivered another strong fundamental quarter, reporting 10% organic revenue growth, gross margins of 72.1%, and adjusted EPS of $0.68, exceeding the consensus estimate of $0.66.
Despite these solid operating results, the shares declined following the earnings release as investors took profits in one of the medical device sector’s strongest performers. Prior to reporting first-quarter results on May 5, 2026, LMAT shares had appreciated approximately 38% year-to-date. We continue to believe the company is well positioned to generate attractive revenue and earnings growth over the coming years, supported by its differentiated vascular product portfolio and consistent execution.”